L Percell Robert, E Johnson Matthew, Dendi Raghuveer
SANS FLUORO Institute, Electrophysiology Department, Bryan Heart Institute, 1600 S 48th Street, Lincoln, NE 68506.
Bryan Heart Institute, 1600 S 48th Street, Lincoln, NE 68506.
J Atr Fibrillation. 2021 Feb 28;13(5):2453. doi: 10.4022/jafib.2453. eCollection 2021 Feb-Mar.
We present the first ever reported case of a super morbidly obese patient (BMI > 60) with drug refractory, symptomatic persistent atrial fibrillation who underwent an uncomplicated, but unsuccessful PVI ablation procedure and subsequently underwent AV node ablation and cardiac resynchronization therapy - pacemaker (CRT-P) insertion using a zero fluoroscopy technique. This case demonstrates the following two critical points: (1) difficulties in the treatment of massively obese patients with arrhythmias1; (2) increased use of fluoroless procedures2-4.
我们报告了首例有记录的超级病态肥胖患者(体重指数>60),该患者患有药物难治性、有症状的持续性心房颤动,接受了一次无并发症但未成功的肺静脉隔离(PVI)消融手术,随后接受了房室结消融和使用零透视技术植入心脏再同步治疗起搏器(CRT-P)。该病例展示了以下两个关键点:(1)治疗极度肥胖的心律失常患者存在困难;(2)减少透视手术的使用增加。